Provided by Tiger Trade Technology Pte. Ltd.

Assertio Holdings, Inc.

18.45
+1.9411.75%
Volume:152.90K
Turnover:2.69M
Market Cap:118.39M
PE:-3.89
High:18.50
Open:16.75
Low:16.62
Close:16.51
52wk High:18.50
52wk Low:7.71
Shares:6.42M
Float Shares:5.68M
Volume Ratio:1.23
T/O Rate:2.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7439
EPS(LYR):-4.7439
ROE:-28.25%
ROA:-3.90%
PB:1.26
PE(LYR):-3.89

Loading ...

Assertio Therapeutics Banks on Robodon After Volatile Q4

TIPRANKS
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Assertio Therapeutics (ASRT) and LENSAR (LNSR)

TIPRANKS
·
Mar 17

Alliance Global Partners Reaffirms Their Buy Rating on Assertio Therapeutics (ASRT)

TIPRANKS
·
Mar 17

Assertio's revenue declines sharply in Q4 after Rolvedon sell-in

Reuters
·
Mar 17

Assertio Holdings Q4 Adj. EPS $(1.06) Beats $(2.71) Estimate, Sales $13.542M Miss $16.626M Estimate

Benzinga
·
Mar 17

Assertio Q4 net product sales fell 56.7% to USD 12.8 million as adjusted EBITDA was USD -4.1 million

Reuters
·
Mar 17

BRIEF-Assertio Holdings, Inc. Q4 Adjusted EPS USD -1.06 Vs. IBES Estimate USD -2.71

Reuters
·
Mar 17

Assertio Reports Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS
·
Mar 17

Assertio Holdings, Inc. Q4 Revenue USD 13.5 Million

THOMSON REUTERS
·
Mar 17

Assertio Holdings: 2026 Guidance Net Product Sales $110.0 Mln-$125.0 Mln

THOMSON REUTERS
·
Mar 17

Assertio Holdings: 2026 Guidance Adj Ebitda $28.0 Mln-$40.0 Mln

THOMSON REUTERS
·
Mar 17

Assertio Holdings, Inc. Q4 Income From Operations USD -11.749 Million

THOMSON REUTERS
·
Mar 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 16

Assertio Holdings Inc expected to post a loss of $2.71 a share - Earnings Preview

Reuters
·
Mar 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 13

Press Release: Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Dow Jones
·
Mar 04

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Agenus (AGEN) and Assertio Therapeutics (ASRT)

TIPRANKS
·
Jan 21

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

THOMSON REUTERS
·
Jan 13

Assertio Publishes Study Showing Rolvedon Safe and Effective for Same-Day Dosing with TC Chemotherapy

Reuters
·
Jan 10

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

THOMSON REUTERS
·
Jan 10